A.I. Fraguas-‐Sánchez & al.
576
37. Matias, I.; Bisogno, T.; Di Marzo, V. Endogenous cannabinoids in the brain and peripheral
tissues: regulation of their levels and control of food intake. Int J Obes (Lond), 30 (Suppl 1)
S7-‐S12 (2006).
38. Brown, T. T.; Dobs, A. S. Endocrine effects of marijuana. J Clin Pharmaco, 92 (11 suppl),
90S-‐96S (2002).
39. Battista, N.; Rapino; C.; Di Tommaso, M.; Bari, M.; Pasquariello, N.¸ Maccarrone, M.
Regulation of male fertility by the endocannabinoid system. Mol Cell Endocrinol, 286 (1-‐2
suppl 1), 17S-‐23S (2008).
40. Cota, D. The role of the endocannabinoid system in the regulation of hypothalamic-‐
pituitary-‐adrenal axis activity. J Neuroendocrinol, 20 (suppl 1):35-‐38 (2008).
41. Sun, Y.; Alexander, S. P.; Garle, M. J.; Gibson, C. L.; Hewitt, K.; Murphy, S. P.; Kendall, D. A.;
Bennett, A. J. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Br J Pharmacol, 152 (5), 734-‐743 (2007).
42. O'Sullivan, S. E. Cannabinoids go nuclear: evidence for activation of peroxisome
proliferator-‐activated receptors. Br J Pharmacol, 152 (5), 576-‐582 (2007).
43. Duran, M.; Laporte, J. R.; Capellà, D. Novedades sobre las potencialidades terapéuticas del
Cannabis y el sistema cannabinoide. Med Clin (Barc), 122 (10), 390-‐398 (2004).
44. Lunn, C. A.; Fine, J. S.; Rojas-‐Triana, A.; Jackson, J. V.; Fan, X.; Kung, T.T.; Gonsiorek,
W.; Schwarz, M. A., Lavey, B.; Kozlowski, J. A.; Narula, S. K.; Lundell, D. J.; Hipkin, R. W.;
Bober, L. A. A novel cannabinoid peripheral cannabinoid receptorselective inverse agonist
blocks leukocyte recruitment in vivo. J Pharmacol Exp Ther 316 (2), 780-‐788 (2006).
45. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.;
Herkenham, M.; Mackie, B. R.; Mechoulam, R.; Pertwee, G. nternational Union of
Pharmacology XXVII. Classification of cannabinoid receptors. Pharmacol Rev; 54:161-‐202
(2002).
46. Pertwee, R. G. Ligands that target cannabinoid receptors in the brain: from THC to
anandamide and beyond. Addict Biol; 13 (2), 147-‐159 (2008).
47. Sagredo, O.; García-‐Arencibia, M.; De Lago, E.; Finetti, S.; Decio, A.; Fernández-‐Ruiz, J.
Cannabinoids and neuroprotection in basal ganglia disorders. Mol Neurobiol
,
36 (1), 82-‐91
(2007).
48. Pacher, P.; Kunos, G. Modulating the endocannabinoid system in human health and disease-‐
-‐successes and failures. FEBS J, 280 (9):1918-‐1943 (2013).
49 Booz, G. W. Cannabidiol as an emergent therapeutic strategy for lessening the impact of
inflammation on oxidative stress. Free Radic Biol Med, 51 (5), 1054-‐1061 (2011).
50. Kogan, N. M.; Mechoulam, R. Cannabinoids in health and disease. Dialogues Clin Neurosci. 9
(4), 413-‐430 (2007).
51. Fernández-‐Ruiz, J.; Romero, J.; Velasco, G.; Tolón, R. M.; Ramos, J. A.; Guzmán, M.
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?. Trends
Pharmacol Sci; 28 (1), 39-‐45 (2007).
52. Croxford, J. L.; Yamamura, T. Cannabinoids and the immune system: potential for the
treatment of inflammatory diseases?. J Neuroimmunol, 166 (1-‐2), 3-‐18 (2005).
53. Baker, D.; Jackson, S. J.; Pryce, G. Cannabinoid control of neuroinflammation related to
multiple sclerosis. Br J Pharmacol, 152 (5), 649-‐654 (2007).
54. Baker, D.; Pryce, G. The endocannabinoid system and multiple sclerosis. Curr Pharm Des,
14 (23), 2326-‐2336 (2008).
54. Fernández-‐Ruiz, J.; Romero, J.; Velasco, G.; Tolón, R. M.; Ramos, J. A.; Guzmán, M.
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?. Trends
Pharmacol Sci; 28 (1), 39-‐45 (2007).
55. Ryan, D.; Drysdale, A. J.; Lafourcade, C.; Pertwee, R. G.; Platt, B. Cannabidiol targets
mitochondria to regulate intracellular Ca
2+
levels. J Neurosci, 29 (7) 2053-‐2063 (2009).
56. Croxford, J. L.; Yamamura, T. Cannabinoids and the immune system: potential for the
treatment of inflammatory diseases?. J Neuroimmunol, 166 (1-‐2), 3-‐18 (2005).
56. Saito, V. M.; Rezende, R. M.; Teixeira, A. L. Cannabinoid modulation of neuroinflammatory
disorders. Curr Neuropharmacol, 10 (2), 159-‐66 (2012).
57. Aso, E.; Ferrer, I. Cannabinoids for treatment of Alzheimer's disease: moving toward the
clinic. Front Pharmacol, 5, 1-‐11 (2014).
58. Ruiz-‐Valdepeñas, L.; Benito, C.; Tolón, R. M.; Martínez Orgado, J. A.; Romero, J. The
endocannabinoid system and amyloid-‐related diseases. Exp Neurol, 224 (1), 66-‐73 (2010).
